e-learning
resources
Vienna 2003
Sunday 28.09.2003
Management and resistance features in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report
M. S. Shelgaonkar, R. P. Munje, S. D. Shelgaonkar, S. N. Umathe (Nagpur, India)
Source:
Annual Congress 2003 - Management and resistance features in tuberculosis
Session:
Management and resistance features in tuberculosis
Session type:
Poster Discussion
Number:
373
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. S. Shelgaonkar, R. P. Munje, S. D. Shelgaonkar, S. N. Umathe (Nagpur, India). Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report. Eur Respir J 2003; 22: Suppl. 45, 373
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient
Source: Eur Respir J 2005; 26: Suppl. 49, 655s
Year: 2005
Kinetics of plasma osteopontin during treatment in patients with pulmonary tuberculosis. A preliminary study
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Paucibacillary pulmonary tuberculosis: Evaluation of clinical profile and study of radiological review
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Factors associated to pulmonary tuberculosis sequelae: A pilot study
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019
Nutritional deficiency in patients with pulmonary tuberculosis
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Lipid profile in tuberculous patients: a preliminary report
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Household TB case finding results and clinical improvement of children with endobronchial tuberculosis
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009
Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002
Nutritional status survey in pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005
Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017
The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects
Year: 2011
The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Morphological evidence of anti-inflammatory effect of interferon-α at pulmonary TB patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Effect of isolated pulmonary rehabilitation vs. associated with a specific protein supplement on exercise test in patients with bronchiectasis: A randomized study
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015
Clinical profile and outcome of complicated pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept